IPSC-Based Gamma-Delta T-Cells, Compositions and Methods of Use Thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Mar 27, 2025
app pub date -
Oct 8, 2024
filing date -
Oct 8, 2024
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
Described are methods of preparing precursor cell-derived induced pluripotent stem cells (iPSCs) and methods of generating iPSC-derived gd T-cells. The invention also includes cell populations comprising the iPSCs, cell populations comprising the iPSC-derived gd T-cells, pharmaceutical compositions comprising the cell populations, and methods of treating cancer comprising administration of the cell population or pharmaceutical composition thereof.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully